Cargando…
Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China
BACKGROUND: Although inactivated COVID-19 vaccines are proven to be safe and effective in the general population, the dynamic response and duration of antibodies after vaccination in the real world should be further assessed. METHODS: We enrolled 1067 volunteers who had been vaccinated with one or t...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110235/ https://www.ncbi.nlm.nih.gov/pubmed/36928099 http://dx.doi.org/10.7554/eLife.84056 |
_version_ | 1785027228106489856 |
---|---|
author | Zhang, Hangjie Hua, Qianhui Nani Xu, Nani Zhang, Xinpei Chen, Bo Ma, Xijun Hu, Jie Chen, Zhongbing Yu, Pengfei Lei, Huijun Wang, Shenyu Ding, Linling Fu, Jian Liao, Yuting Yang, Juan Jiang, Jianmin Lv, Huakun |
author_facet | Zhang, Hangjie Hua, Qianhui Nani Xu, Nani Zhang, Xinpei Chen, Bo Ma, Xijun Hu, Jie Chen, Zhongbing Yu, Pengfei Lei, Huijun Wang, Shenyu Ding, Linling Fu, Jian Liao, Yuting Yang, Juan Jiang, Jianmin Lv, Huakun |
author_sort | Zhang, Hangjie |
collection | PubMed |
description | BACKGROUND: Although inactivated COVID-19 vaccines are proven to be safe and effective in the general population, the dynamic response and duration of antibodies after vaccination in the real world should be further assessed. METHODS: We enrolled 1067 volunteers who had been vaccinated with one or two doses of CoronaVac in Zhejiang Province, China. Another 90 healthy adults without previous vaccinations were recruited and vaccinated with three doses of CoronaVac, 28 days and 6 months apart. Serum samples were collected from multiple timepoints and analyzed for specific IgM/IgG and neutralizing antibodies (NAbs) for immunogenicity evaluation. Antibody responses to the Delta and Omicron variants were measured by pseudovirus-based neutralization tests. RESULTS: Our results revealed that binding antibody IgM peaked 14–28 days after one dose of CoronaVac, while IgG and NAbs peaked approximately 1 month after the second dose then declined slightly over time. Antibody responses had waned by month 6 after vaccination and became undetectable in the majority of individuals at 12 months. Levels of NAbs to live SARS-CoV-2 were correlated with anti-SARS-CoV-2 IgG and NAbs to pseudovirus, but not IgM. Homologous booster around 6 months after primary vaccination activated anamnestic immunity and raised NAbs 25.5-fold. The neutralized fraction subsequently rose to 36.0% for Delta (p=0.03) and 4.3% for Omicron (p=0.004), and the response rate for Omicron rose from 7.9% (7/89)–17.8% (16/90). CONCLUSIONS: Two doses of CoronaVac vaccine resulted in limited protection over a short duration. The inactivated vaccine booster can reverse the decrease of antibody levels to prime strain, but it does not elicit potent neutralization against Omicron; therefore, the optimization of booster procedures is vital. FUNDING: Key Research and Development Program of Zhejiang Province; Key Program of Health Commission of Zhejiang Province/ Science Foundation of National Health Commission; Major Program of Zhejiang Municipal Natural Science Foundation; Explorer Program of Zhejiang Municipal Natural Science Foundation. |
format | Online Article Text |
id | pubmed-10110235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-101102352023-04-18 Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China Zhang, Hangjie Hua, Qianhui Nani Xu, Nani Zhang, Xinpei Chen, Bo Ma, Xijun Hu, Jie Chen, Zhongbing Yu, Pengfei Lei, Huijun Wang, Shenyu Ding, Linling Fu, Jian Liao, Yuting Yang, Juan Jiang, Jianmin Lv, Huakun eLife Epidemiology and Global Health BACKGROUND: Although inactivated COVID-19 vaccines are proven to be safe and effective in the general population, the dynamic response and duration of antibodies after vaccination in the real world should be further assessed. METHODS: We enrolled 1067 volunteers who had been vaccinated with one or two doses of CoronaVac in Zhejiang Province, China. Another 90 healthy adults without previous vaccinations were recruited and vaccinated with three doses of CoronaVac, 28 days and 6 months apart. Serum samples were collected from multiple timepoints and analyzed for specific IgM/IgG and neutralizing antibodies (NAbs) for immunogenicity evaluation. Antibody responses to the Delta and Omicron variants were measured by pseudovirus-based neutralization tests. RESULTS: Our results revealed that binding antibody IgM peaked 14–28 days after one dose of CoronaVac, while IgG and NAbs peaked approximately 1 month after the second dose then declined slightly over time. Antibody responses had waned by month 6 after vaccination and became undetectable in the majority of individuals at 12 months. Levels of NAbs to live SARS-CoV-2 were correlated with anti-SARS-CoV-2 IgG and NAbs to pseudovirus, but not IgM. Homologous booster around 6 months after primary vaccination activated anamnestic immunity and raised NAbs 25.5-fold. The neutralized fraction subsequently rose to 36.0% for Delta (p=0.03) and 4.3% for Omicron (p=0.004), and the response rate for Omicron rose from 7.9% (7/89)–17.8% (16/90). CONCLUSIONS: Two doses of CoronaVac vaccine resulted in limited protection over a short duration. The inactivated vaccine booster can reverse the decrease of antibody levels to prime strain, but it does not elicit potent neutralization against Omicron; therefore, the optimization of booster procedures is vital. FUNDING: Key Research and Development Program of Zhejiang Province; Key Program of Health Commission of Zhejiang Province/ Science Foundation of National Health Commission; Major Program of Zhejiang Municipal Natural Science Foundation; Explorer Program of Zhejiang Municipal Natural Science Foundation. eLife Sciences Publications, Ltd 2023-03-16 /pmc/articles/PMC10110235/ /pubmed/36928099 http://dx.doi.org/10.7554/eLife.84056 Text en © 2023, Zhang, Hua et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Epidemiology and Global Health Zhang, Hangjie Hua, Qianhui Nani Xu, Nani Zhang, Xinpei Chen, Bo Ma, Xijun Hu, Jie Chen, Zhongbing Yu, Pengfei Lei, Huijun Wang, Shenyu Ding, Linling Fu, Jian Liao, Yuting Yang, Juan Jiang, Jianmin Lv, Huakun Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China |
title | Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China |
title_full | Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China |
title_fullStr | Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China |
title_full_unstemmed | Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China |
title_short | Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China |
title_sort | evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated covid-19 vaccine (coronavac): a cross-sectional and cohort study in zhejiang, china |
topic | Epidemiology and Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110235/ https://www.ncbi.nlm.nih.gov/pubmed/36928099 http://dx.doi.org/10.7554/eLife.84056 |
work_keys_str_mv | AT zhanghangjie evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT huaqianhui evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT nanixunani evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT zhangxinpei evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT chenbo evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT maxijun evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT hujie evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT chenzhongbing evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT yupengfei evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT leihuijun evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT wangshenyu evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT dinglinling evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT fujian evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT liaoyuting evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT yangjuan evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT jiangjianmin evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina AT lvhuakun evaluationofantibodykineticsanddurabilityinhealthyindividualsvaccinatedwithinactivatedcovid19vaccinecoronavacacrosssectionalandcohortstudyinzhejiangchina |